144 related articles for article (PubMed ID: 9544385)
1. Graves' ophthalmopathy: pathogenesis and clinical implications.
Major BJ; Busuttil BE; Frauman AG
Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
[No Abstract] [Full Text] [Related]
2. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
3. Immunogenetics of endocrine ophthalmopathy and Graves' disease.
Badenhoop K; Schleusener H; Usadel KH
Dev Ophthalmol; 1993; 25():11-9. PubMed ID: 8359345
[No Abstract] [Full Text] [Related]
4. [Orbit pathology and Graves' ophthalmopathy].
Stankiewicz A
Klin Oczna; 1997; 99(1):59-63. PubMed ID: 9379657
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of Graves' disease.
Pittman CS; Menefee JK
Hosp Pract (Off Ed); 1987 May; 22(5):147-57, 162-4. PubMed ID: 3106370
[No Abstract] [Full Text] [Related]
6. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Nakahara M; Johnson K; Eckstein A; Taguchi R; Yamada M; Abiru N; Nagayama Y
Endocrinology; 2012 Apr; 153(4):2034-42. PubMed ID: 22334716
[TBL] [Abstract][Full Text] [Related]
7. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy.
Shokeir MO; Pudek MR; Katz S; Rootman J; Kendler DL
Clin Biochem; 1996 Apr; 29(2):187-9. PubMed ID: 8601331
[No Abstract] [Full Text] [Related]
8. Back to the drawing board for antigens in endocrine ophthalmopathy?
Ludgate M
Dev Ophthalmol; 1993; 25():86-92. PubMed ID: 7689491
[No Abstract] [Full Text] [Related]
9. Immunogenetic markers in patients with Graves' disease.
Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
[TBL] [Abstract][Full Text] [Related]
10. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
11. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
13. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
14. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease: clinical correlation with autoantibody activity.
Valente WA
Md Med J; 1988 Nov; 37(11):866-9. PubMed ID: 3054388
[No Abstract] [Full Text] [Related]
16. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease.
Watson PF; French A; Pickerill AP; McIntosh RS; Weetman AP
J Clin Endocrinol Metab; 1995 Mar; 80(3):1032-5. PubMed ID: 7883818
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
19. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
20. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy.
Paschke R; Vassart G; Ludgate M
Clin Endocrinol (Oxf); 1995 Jun; 42(6):565-9. PubMed ID: 7634495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
